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Treacher Collins syndrome (TCS) is an autosomal dominant disorder of craniofacial development with features
including malar hypoplasia, micrognathia, microtia, downward slanting palpebral fissures, lower eyelid
coloboma, conductive hearing loss, and cleft palate. TCS is caused by mutations in the TCOF1 gene, which
encodes the nuclear phosphoprotein treacle. Here, we describe a 1-day-old male infant with classical TCS
presentation. A 5-bp deletion in exon 22 of the TCOF1 gene (3469del ACTCT) was found to cause a premature
stop codon. This is the first report of TCOF1 gene mutation in the Taiwanese population. [J Formos Med Assoc
2006;105(6):518–521]
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Treacher Collins syndrome (TCS), also known as
Franceschetti-Zwahlen-Klein syndrome and man-
dibulofacial dysostosis, OMIM 154500, is an
autosomal dominant craniofacial disorder affect-
ing the development of structures derived from the
first and second branchial arches during the 5th–
8th week of embryonic development.1 It has an es-
timated incidence of 1 in 50,000 live births.2 The
major diagnostic criteria of TCS include bilaterally
symmetric midface hypoplasia, downward slant of
palpebral fissures, lower eyelid coloboma, micro-
gnathia, microtia, and other deformities of the ear
often leading to conductive hearing loss. The phe-
notype is so variable that it may range from peri-
natal death due to a compromised airway at one
end of the spectrum, to cases that go undetected
under clinical examination.2,3 This marked varia-
bility can make diagnosis difficult, especially in
cases that do not show all the canonical signs of
the syndrome.
The gene underlying this syndrome, TCOF1,
was cloned in 1996 by the Treacher Collins Syn-
drome Collaborative Group and designated trea-
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cle.4 The TCOF1 gene contains 26 exons and en-
codes a 1411-amino acid protein. More than 105
pathogenic mutations have been described.5 Most
of these mutations are insertions or deletions that
result in an introduction of a premature termina-
tion codon into the reading frame. Mutational spec-
tra support the hypothesis that TCS results from
haploinsufficiency of treacle,6 because of the in-
creased level of apoptosis in the prefusion neural
fold and severe defects in craniofacial development
in mouse embryos with one allele of TCOF1 gene
ablated.7 Here, we report a case of TCS with a de
novo deletion in the TCOF1 gene.
Case Report
This male neonate was transferred to the neona-
tal intensive care unit immediately after birth be-
cause of congenital facial anomalies and respira-
tory distress. He had downward slanting palpe-
bral fissures, sunken cheek bones, receding chin,
micrognathia, bilateral microtia, absent eyelashes
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Because of the compromised airway, the pa-
tient had frequent episodes of respiratory dis-
tress, and died of respiratory and heart failure
at the age of 60 days. One year later, under close
prenatal three-dimensional (3D) sonographic
surveillance, the mother delivered a normal female
baby.
Discussion
Differential diagnosis of TCS includes Goldenhar
syndrome (oculoauriculovertebral dysplasia),
which has the characteristic features of unilateral
notching of the upper rather than the lower eye-
lid and epibulbar dermoids,9 and Nager acrofa-
cial dysostosis, which presents with mandibulofa-
cial dysostosis with preaxial reduction defects of
the upper limbs.
of the right lower eyelid, epicanthus inversus, pto-
sis, external ear canal defect, and cleft palate (Figure
1). Head computed tomography demonstrated
maxillar and mandibular hypoplasia, bilateral
auditory canal atresia, and poorly pneumatized
mastoid. Bronchoscopy demonstrated laryngo-
malacia. Brainstem auditory evoked potentials
(BAEP) showed conductive deafness. Cytogenetic
analysis revealed a normal 46,XY karyotype.
Genomic DNA was isolated from the whole
blood of the patient and his parents. Exon 1 to
exon 26 of the TCOF1 gene were amplified by
polymerase chain reaction (PCR) under optimal
conditions, using specific primers.8 Sequencing
analysis of the PCR products revealed six poly-
morphisms; five were silent and one caused an
alanine to valine change (A810V) (Table). A 5-
bp deletion in exon 22 (3469del ACTCT), which
caused a premature stop codon, was also found.
This deletion was not present in the patient’s par-
ents and normal controls. Therefore, it is a de novo
mutation (Figure 2).
Figure 1. The patient at age 12 days: (A) downward slanting
palpebral fissures, sunken cheekbones, micrognathia; (B) microtia







Exon 16 Exon 22
Patient: 2429 C  ➞T Patient: 3469del ACTCT  
Patient’s father: 2429 C➞C/T Patient’s father
Normal: 2429 C➞T Normal
Patient’s mother: 2429 C➞C/T Patient’s mother
Figure 2. The partial sequence of exons 16 and 22 of the: (A) patient; (B) patient’s
father; (C) patient’s mother; (D) normal control.
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TCS is considered a neonatal emergency be-
cause the tongue may obstruct the airway. An-
tenatal diagnosis of TCS using conventional two-
dimensional (2D) sonography depends on the
midsagittal scan of the fetal face.10,11 However, in
1997, Merz et al reported that the facial profile
shown in the 2D image represented the true mid-
sagittal profile in only 69.6% of cases studied,
while surface rendering using 3D sonography
was able to provide more useful striking images
of the fetal face.12 In 2002, Tanaka et al reported
the antenatal sonographic features in the case
of a Japanese woman at 36 weeks of gestation
referred for polyhydramnios.13 Hsu et al reported
a Taiwanese woman at 34 weeks of gestation re-
ferred for polyhydramnios and fetal anomaly.14
These cases suggest the value of 3D imaging in
monitoring at-risk pregnancies. Without specific
past histories, this congenital anomaly will not be
detected by routine antenatal examination.
Mutations detected previously5 in TCS indicate
that: (1) the majority of pathogenic mutations are
small deletions and insertions causing frameshifts
that lead to truncation of the protein; (2) muta-
tions (both polymorphic and pathogenic) can be
found throughout the 25 coding exons of the gene;
(3) most mutations are family-specific, with the
exception of a commonly occurring 5-bp deletion
in exon 24 (found in approximately 16% of
families); and (4) there is no correlation between
type and/or localization of the mutation and phe-
notypic expression.15 More than 50% of all de-
scribed pathogenic known mutations are clus-
tered in five exons (10, 15, 16, 23, 24) in differ-
ent populations.16 The 5-bp deletion in exon 22,
3469del ACTCT (T1146G), that was found in our
Table. Mutations and polymorphisms found in this study
Exon Mutation Amino acid Effect Protein product Reference
9 1247 A➞G E419E Silent mutation Polymorphism This study
10 1347 T➞C P449P Silent mutation Polymorphism 8
11 1611 G➞A S537S Silent mutation Polymorphism 8
16 2429 C➞T A810V Missense Polymorphism 8
17 2793 C➞T P931P Silent mutation Polymorphism This study
17 2952 A➞G Q984Q Silent mutation Polymorphism This study
22 3469del ACTCT T1146G Frameshift Aborted translocation This study
patient has not been reported previously, and is
not located within the mutational hot spots.
Because of the marked phenotypic variability
in TCS, antenatal 3D sonography is very impor-
tant to confirm the diagnosis, especially in the
presence of craniofacial dysostosis in previous
pregnancies. DNA analysis is also very helpful in
confirming the diagnosis.
References
1. Poswillo D. The pathogenesis of the Treacher Collins syn-
drome (mandibulofacial dysostosis). Br J Oral Surg 1975;
13:1–26.
2. Gorlin RJ, Cohen MM, Hennekam RCM. Syndromes of the
Head and Neck, 4th edition. New York: Oxford University
Press, 2001:1344.
3. Jones KL. Smith’s Recognizable Patterns of Human
Malformation, 5th edition. Philadelphia: WB Saunders,
1997:861.
4. Treacher Collins Collaborative Group. Positional cloning
of a gene involved in the pathogenesis of Treacher Collins
syndrome. Nat Genet 1996;12:130–6.
5. Marszalek B, Wisniewski SA, Wojcicki P, et al. Novel
mutation in the 5’ splice site of exon 4 of the TCOF1 gene
in the patient with Treacher Collins syndrome. Am J Med
Genet A 2003;123:169–71.
6. Marszalek B, Wojcicki P, Kobus K, et al. Clinical features,
treatment and genetic background of Treacher Collins
syndrome. J Appl Genet 2002;43:223–33.
7. Dixon J, Brakebusch C, Fassler R, et al. Increased levels
of apoptosis in the prefusion neural folds underlie the
craniofacial disorder, Treacher Collins syndrome. Hum Mol
Genet 2000;9:1473–80.
8. Wise CA, Chiang LC, Paznekas WA, et al. TCOF1 gene
encodes a putative nucleolar phosphoprotein that exhibits
mutations in Treacher Collins syndrome throughout its
coding region. Proc Nat Acad Sci 1997;94:3110–5.
9. Meizner I, Carmi B, Katz M. Prenatal ultrasonic diagnosis
of mandibulofacial dysostosis (Treacher Collins syndrome).
521J Formos Med Assoc | 2006 • Vol 105 • No 6
Treacher Collins syndrome
J Clin Ultrasound 1991;19:124–7.
10. Cohen J, Ghezzi F, Gongalves L, et al. Prenatal sonographic
diagnosis of Treacher Collins syndrome: a case and re-
view of the literature. Am J Perinatol 1995;12:416–9.
11. Ochi H, Matsubara K, Ito M, et al. Prenatal sonographic
diagnosis of Treacher Collins syndrome. Obstet Gynecol
1998;91:862.
12. Merz E, Weber G, Bahlmann F, et al. Application of trans-
vaginal and abdominal three-dimensional ultrasound for
the detection or exclusion of malformations of the fetal face.
Ultrasound Obstet Gynecol 1997;9:237–43.
13. Tanaka Y, Miyazaki T, Kanenishi K, et al. Antenatal three-
dimensional sonographic features of Treacher Collins syn-
drome. Ultrasound Obstet Gynecol 2002;19:414–5.
14. Hsu TY, Hsu JJ, Chang SY. Prenatal three-dimensional
sonographic images associated with Treacher Collins
syndrome. Ultrasound Obstet Gynecol 2002;19:413–4.
15. Splendore A, Silva EO, Alonso LG, et al. High mutation
detection rate in TCOF1 among Treacher Collins syndrome
patients reveals clustering of mutations and 16 novel
pathogenic changes. Hum Mutat 2000;16:315–22.
16. Splendore A, Jabs EW, Passos-Bueno MR. Screening of
TCOF1 in patients from different populations: confirmation
of mutational hot spots and identification of a novel missense
mutation that suggests an important functional domain in
the protein treacle. J Med Genet 2002;39:493–5.
